Enorama Pharma AB Cash Flow Reinvestment Rate
Enorama Pharma AB cash flow reinvestment rate. Enorama Pharma AB (ERMA) has a Cash Flow Reinvestment Rate of 0.00x as of December 2015, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr760.00K. Explore debt repayment capacity of Enorama Pharma AB to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Enorama Pharma AB (2014–2015)
Cash flow reinvestment rate of Enorama Pharma AB from 2014 to 2015. Historical reinvestment intensity for Enorama Pharma AB across 2 annual periods. Explore ERMA capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Enorama Pharma AB Cash Flow Reinvestment Rate by Year (2014–2015)
Enorama Pharma AB cash flow reinvestment rate by year from 2014 to 2015. Year-by-year capital reinvestment analysis for Enorama Pharma AB. For the full cash flow conversion analysis, see ERMA operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2015 | 4.15x | Skr1.99 Million | Skr480.00K | Skr1.99 Million | ▼ -7.8% |
| 2014 | 4.50x | Skr1.38 Million | Skr307.00K | Skr1.38 Million | — |